[ Price : $8.95]
Federal Register notice: FDA announces a 10/17 joint advisory committee meeting to review an irritable bowel syndrome drug.[ Price : $8.95]
FDA warns Canadas Lernapharm about CGMP violations in its production of finished drugs.[ Price : $8.95]
Four pharmaceutical stakeholders submit comments on an FDA draft guidance on writing the Indications and Usage section in product ...[ Price : $8.95]
Indias Lupin says an FDA inspection at its Tarapur drug manufacturing facility closed with one observation the company considers t...[ Price : $8.95]
FDA warns Chinas Longwood Medicine (Beijing) about CGMP violations in its production of an unapproved new drug.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Postapproval Changes to Drug Substances.[ Price : $8.95]
Federal Register notice: FDA submits to OMB an information collection extension Guidance for Industry: Formal Meetings between the...[ Price : $8.95]
Former FDA chief counsel Rebecca Wood rejoins Sidley Austin to co-lead both the firms food, drug and medical device regulatory pra...